Search Results - Zuo, Y.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

    First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, EN... by Wu, Y.L., Zhou, C., Liam, Chong Kin, Wu, G., Liu, X., Zhong, Z., Lu, S., Cheng, Y., Han, B., Chen, L., Huang, C., Qin, S., Zhu, Y., Pan, H., Liang, H., Li, E., Jiang, G., How, S.H., Fernando, M.C.L., Zhang, Y., Xia, F., Zuo, Y.

    Published 2015
    Get full text
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: